Veyrac G - Search Results

1

Safety concerns on the abuse potential of esketamine: Multidimensional analysis of a new anti-depressive drug on the market.

Baudot J, Soeiro T, Tambon M, Navarro N, Veyrac G, Mezaache S, Micallef J. Baudot J, et al. Among authors: veyrac g. Fundam Clin Pharmacol. 2022 Jun;36(3):572-581. doi: 10.1111/fcp.12745. Epub 2021 Dec 23. Fundam Clin Pharmacol. 2022. PMID: 34907579

2

[Clinical data on COX-1 and COX-2 inhibitors: what possible alerts in pharmacovigilance?].

Larousse C, Veyrac G. Larousse C, et al. Among authors: veyrac g. Therapie. 2000 Jan-Feb;55(1):21-8. Therapie. 2000. PMID: 10859997 Review. French.

3

Evidence of zolpidem abuse and dependence: results of the French Centre for Evaluation and Information on Pharmacodependence (CEIP) network survey.

Victorri-Vigneau C, Dailly E, Veyrac G, Jolliet P. Victorri-Vigneau C, et al. Among authors: veyrac g. Br J Clin Pharmacol. 2007 Aug;64(2):198-209. doi: 10.1111/j.1365-2125.2007.02861.x. Epub 2007 Feb 23. Br J Clin Pharmacol. 2007. PMID: 17324242 Free PMC article. Review.

4

[MEOPA use practices in a university hospital: Which conformity?].

Victorri-Vigneau C, Paille C, Joyau C, Veyrac G, Cosset C, Le Pelletier A, Jolliet P, Nizard J, Kuhn E. Victorri-Vigneau C, et al. Among authors: veyrac g. Therapie. 2017 Dec;72(6):659-663. doi: 10.1016/j.therap.2017.04.003. Epub 2017 May 26. Therapie. 2017. PMID: 28647109 French.

5

[A 2-year evaluation of questions concerning "Drugs--Pregnancy" at the CRPV in Nantes March 1992--March 1994].

Chiffoleau A, Veyrac G, Baudot S, Larousse C. Chiffoleau A, et al. Among authors: veyrac g. Therapie. 1995 Sep-Oct;50(5):429-38. Therapie. 1995. PMID: 8571281 French.

6

Lamotrigine-induced neutropenia following two attempts to increase dosage above 50 mg/day with recovery between episodes.

Lambert O, Veyrac G, Armand C, Bourlon S, Bourin M, Jolliet P. Lambert O, et al. Among authors: veyrac g. Adverse Drug React Toxicol Rev. 2002;21(3):157-9. doi: 10.1007/BF03256191. Adverse Drug React Toxicol Rev. 2002. PMID: 12298424 No abstract available.

7

Neurocognitive Disorders Associated with PCSK9 Inhibitors: a Pharmacovigilance Disproportionality Analysis.

Gouverneur A, Sanchez-Pena P, Veyrac G, Salem JE, Bégaud B, Bezin J. Gouverneur A, et al. Among authors: veyrac g. Cardiovasc Drugs Ther. 2023 Apr;37(2):271-276. doi: 10.1007/s10557-021-07242-7. Epub 2021 Aug 26. Cardiovasc Drugs Ther. 2023. PMID: 34436707

8

Bacterial infections and NSAIDs exposure? Seek septic complications.

Le Turnier P, Boutoille D, Joyau C, Veyrac G, Asseray N. Le Turnier P, et al. Among authors: veyrac g. Eur J Intern Med. 2017 Jun;41:e33-e34. doi: 10.1016/j.ejim.2017.03.004. Epub 2017 Mar 13. Eur J Intern Med. 2017. PMID: 28302389

9

Pristinamycin-induced arthralgia and myalgia: Analysis of the French Pharmacovigilance Database.

Denis Prevot M, Thillard EM, Walther J, Veyrac G, Laroche ML, Gautier S, Auffret M. Denis Prevot M, et al. Among authors: veyrac g. Med Mal Infect. 2018 Feb;48(1):58-62. doi: 10.1016/j.medmal.2017.09.014. Epub 2017 Oct 28. Med Mal Infect. 2018. PMID: 29110913

10

[Cutaneous application of monoxidil during pregnancy: hairy infant].

Veyrac G, Chiffoleau A, Bailly C, Baudot S, Beaudouin S, Larousse C. Veyrac G, et al. Therapie. 1995 Sep-Oct;50(5):474-6. Therapie. 1995. PMID: 8571293 French. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

52 results

Search Page

Filters